Epilepsy is the most common, serious, neurological disorder and is characterised by epileptic seizures. It is one of the world’s most prevalent non-communicable diseases; the World Health Organisation estimates that epilepsy affects around 1% of the global population. 1 Danone Research & Innovation has played a pioneering role in the development of a range of medical nutritional solutions for the ketogenic diet, which helps support the nutritional needs of adults and children with difficult to manage (‘refractory’, ‘drug-resistant’) epilepsy.